XML 36 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Balance at Jun. 30, 2023 $ 1,942 $ (1) $ 46,180,112 $ (41,807,573) $ (575,496) $ (111,986) $ 3,686,998
Balance, shares at Jun. 30, 2023 194,200            
Balance, shares at Jun. 30, 2023     (116)          
Issuance of common stock, Series E Preferred Stock and warrants, net of issuance costs $ 57,287 $ 1,860 3,727,017 3,786,164
Issuance of common stock, Series E preferred stock and warrants, net of issuance costs, shares 5,728,723 186,018            
Conversion of convertible preferred shares into common stock $ (57,287) $ 4,774 52,513
Conversion of convertible preferred shares into common stock, shares (5,728,723) 477,394            
Conversion of holdback Series C Preferred Stock into common stock $ 62 32,700 32,762
Conversion of holdback Series C Preferred Stock into common stock, shares   6,248            
Issuance of common stock upon exercise of warrants $ 6,551 (6,122) 429
Issuanceof common stock upon cashless exercise of warrants, shares   655,086            
Reverse stock split rounding adjustment $ 475 (475)
Reverse stock split rounding adjustment, shares   47,501            
Issuance of common stock upon cash exercise of Series E warrants $ 6,291 1,645,207 1,651,498
Issuance of common stock upon cash exercise of Series E warrants, shares   629,409            
Issuance of restricted stock to vendors $ 479 216,342 216,821
Issuance of restricted stock to vendors, shares   47,889            
Issuance of common stock, Series I, H1 and H2 warrants, net of issuance costs $ 6,752 9,110,829 9,117,581
Issuance of common stock, Series I, H1 and H2 warrants, net of issuance costs, shares   675,183            
Issuance of common stock upon exercise of Pre-funded warrants $ 5,313 5,313
Issuance of common stock upon exercise of Pre-funded warrants, shares   531,310            
Stock awards issued to employees $ 58 13,617 13,675
Stock awards issued to employees, shares   5,762            
Foreign currency translation gain (loss) (137,118) (137,118)
Net loss (10,156,759) (34,173) (10,190,932) [1]
Balance at Jun. 30, 2024 $ 34,557 $ (1) 60,971,740 (51,964,332) (712,614) (146,159) $ 8,183,191
Balance, shares at Jun. 30, 2024 3,456,000            
Balance, shares at Jun. 30, 2024     (116)         116
Issuance of common stock upon exercise of warrants $ 7,994 (55) $ 7,939
Issuanceof common stock upon cashless exercise of warrants, shares   799,447            
Issuance of common stock upon cash exercise of Series E warrants               $ 7,939
Issuance of common stock upon cash exercise of Series E warrants, shares               799,447
Issuance of restricted stock to vendors $ 337 47,663 $ 48,000
Issuance of restricted stock to vendors, shares   33,655            
Stock awards issued to employees $ 995 189,050 190,045
Stock awards issued to employees, shares   99,500            
Foreign currency translation gain (loss) 384,670 384,670
Net loss (10,568,733) (36,153) (10,604,886) [1]
Issuance of common stock, net of issuance costs $ 29,347 4,575,518 4,604,865
Issuance of common stock, net of issuance costs, shares   2,934,659            
Balance at Jun. 30, 2025 $ 73,230 $ (1) $ 65,783,916 $ (62,533,065) $ (327,944) $ (182,312) $ 2,813,824
Balance, shares at Jun. 30, 2025 7,323,261            
Balance, shares at Jun. 30, 2025     (116)         116
[1] Comparative amounts for the prior period have been reclassified to conform to current period presentations.